Cargando…
A model of persistent post SARS-CoV-2 induced lung disease for target identification and testing of therapeutic strategies
COVID-19 survivors develop post-acute sequelae of SARS-CoV-2 (PASC), but the mechanistic basis of PASC-associated lung abnormalities suffers from a lack of longitudinal samples. Mouse-adapted SARS-CoV-2 MA10 produces an acute respiratory distress syndrome (ARDS) in mice similar to humans. To investi...
Ejemplares similares
-
SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice
por: Dinnon, Kenneth H., et al.
Publicado: (2022) -
A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice
por: Leist, Sarah R., et al.
Publicado: (2020) -
Anionic Pulmonary Surfactant Lipid Treatment Inhibits Rhinovirus A Infection of the Human Airway Epithelium
por: Numata, Mari, et al.
Publicado: (2023) -
A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures
por: Dinnon, Kenneth H., et al.
Publicado: (2020) -
Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination
por: Adams, Lily E., et al.
Publicado: (2023)